Frontotemporal dementia, chromosome 17, and progranulin

Annals of Neurology

Volumn 60, Issue 3, 2006, Pages 275-277

  Rowland, Lewis P ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN; TAU PROTEIN;

CHROMOSOME 17; EDITORIAL; FRONTOTEMPORAL DEMENTIA; GENE LOCUS; GENE MUTATION; HUMAN; MOTOR NEURON DISEASE; NIEMANN PICK DISEASE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 17; DEMENTIA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;

EID: 33749493778     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20962     Document Type: Editorial

References (36)

1. Mukherjee O, Pastor PN, Cairns NJ, et al. HDDD2 is a familial frontotemporal lobar degeneration with Ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 2006;60:314-322.
2. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006 (in press).
3. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006 (in press).
4. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005;6:771-780.
5. Brun A. Frontal lobe degeneration of non-Alzheimer type. 1. Neuropathology. Arch Gerontol Geriatr 1987;6:193-208.
6. Rowland LP. Primary lateral sclerosis, hereditary spastic paraplegia, and mutations in the alsin gene: historical background for the first international conference. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:67-76.
7. Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57:416-418.
8. Jackson M, Lennox G, Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration 1996;5:339-350.
9. Wilhelmsen KC, Lynch T, Pavlou E, et al. Localization of dis-inhibtion dementia parkinsonism amyotrophy complex to 17q21-22. Am J Hum Genet 1994;55:1159-1165.
10. Foster NI, Wilhelmsen K, Sima AA, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17; a consensus conference. Ann Neurol 1997;41:706-715.
11. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705.
12. Bird TD, Nochin D, Pookaj P, et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 1999;122:741-756.
13. Spillanti MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 1998;95:7737-7741.
14. Dumanchin C, Camuzat A, Campion D, et al. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet 1998;7:1825-1829.
15. Clark LN, Poorkaj P, Wszolek Z, et al. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 1998;95:13103-13107.
16. Mirra SS, Murrell JR, Gearing M, et al. Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol 1999;58:335-345.
17. Bronner IF, ter Meulen BC, Azmani A, et al. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain 2005;128:2645-2653.
18. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia. Report of the Work Group on frontotemporal dementia and Pick's disease. Arch Neurol 2001;58:1803-1809.
19. Hodges JB. Frontotemporal dementia (Pick's disease): clinical features and assessment. Neurology 2001;56(suppl 4):S6-S10.
20. Rossor MN. Pick's disease: a clinical overview. Neurology 2001;56(suppl 4):S3-S5.
21. Martinaud O, Laquerriére A, Guyant-Maréchal L, et al. Frontotemporal dementia, motor neuron disease and tauopathy: clinical and neuropathological study in a family. Acta Neuropathol 2005;110:84-92.
22. Rosso SM, Kamphorst W, de Graaf B, et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 2001;124:1948-1957.
23. Mackenzie IR, Feldman HH. Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J Neuropathol Exp Neurol 2005;64:730-739.
24. Van der Zee J, Radermakers R, Engelborghs S, et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 2006;129:841-852.
25. Wilhelmsen KC, Forman MS, Rosen HJ, et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without Tau mutations with tau and α-synuclein inclusions. Arch Neurol 2004;61:398-406.
26. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005;6:771-780.
27. Murray B, Lynch T, Farrell M. Clinicopathological features of the tauopathies. Biochem Soc Trans 2005;33:595-599.
28. Godert M, Jakes R. Mutations causing neurodegenerative tauopathies. Biochem Biophys Acta 2005;1739:240-250.
29. Forman MS, Farmer J, Johnson JK, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006;59:952-962.
30. Kibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005;37:806-808.
31. Cannon A, Baker M, Boeve B, et al. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neurosci Lett 2006;398:83-84.
32. Annesi G, Savertieri G, Pugliese P, et al. DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Ann Neurol 2005;58:803-807.
33. Forman MS, Mackkenzie IR, Cairns NJ, et al. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutation. J Neuropathol Exp Neurol 2006;65:571-581.
34. Dermaut B, Kumar-Singh S, Engelborghs S, et al. A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 2004;55:617-626.
35. Li X, Rowland LP, Mitsumoto H, et al. Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann Neurol 2005;58:858-864.
36. Hosler BA, Siddique T, Sapp PC, et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 2000;284:1664-1669.